Arcturus Therapeutics Holdings Inc
ARCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$390.53M
Close$
$-3.76
133.8% downside
Current Fair Value
133.8% downsideOvervalued by 133.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $390.53 Million |
|---|---|
| Enterprise Value | $228.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | 2.48 |
| Outstanding Shares | 28,423,000 |
Return
| Return on Equity | -37.47% |
|---|---|
| Return on Assets | -28.70% |
| Return on Invested Capital | -51.89% |
Valuation & Multiples
| P/E Ratio | -4.13 |
|---|---|
| PEG | -2.59 |
| Price to Sales | - |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 12.44 |
| Enterprise Value to EBIT | -2.31 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-1.07
Average shareholder expectationRevenue Estimate
$3.11 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.69
Average shareholder expectationRevenue Estimate
$8.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 156.88% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 88.59% |
|---|---|
| Total Invested | $475,357▼ 99.72% |
| Investors Holding | 5▼ 135.00% |
ESG Score
No data